Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-05-14
1993-09-28
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514947, A01N 4304
Patent
active
052486745
ABSTRACT:
A method of administering 3'-azide-3'-deoxythymidine (AZT) to an AIDS patient who is in need of treatment with AZT, comprising applying AZT to the skin of said patient together with an absorption promoting agent capable of assisting absorption of AZT through the skin into the blood stream of said patient; and a percutaneous composition comprising AZT as an effective Ingredient together with an absorption promoting agent in an amount effective for assisting percutaneous absorption of AZT.
REFERENCES:
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 3991203 (1976-11-01), Rajadhyaksha
patent: 4405616 (1983-09-01), Rajadhyaksha
patent: 4557934 (1985-10-01), Cooper
patent: 4690683 (1987-09-01), Chien et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4818538 (1989-04-01), Rideout et al.
patent: 4828838 (1989-05-01), Rideout et al.
patent: 4833130 (1989-05-01), Rideout et al.
patent: 4837208 (1989-06-01), Rideout et al.
patent: 4847244 (1989-07-01), Rideout et al.
patent: 4883813 (1989-11-01), Maxim et al.
patent: 4900548 (1990-02-01), Kitchen
Seki, et al., "Percutaneous Absorption of Azidothymidine in Rats", International Journal of Pharmaceutics, 57 (1989), pp. 73-75.
Juni Kazuhiko
Kawaguchi Takeo
Morimoto Yasunori
Seki Toshinobu
Sugihayashi Kenji
Horne Leon R.
Josai University
Nelson-Sumisho Co., Ltd.
Page Thurman K.
LandOfFree
Percutaneous administration of 3'-azide'-deoxythymidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Percutaneous administration of 3'-azide'-deoxythymidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneous administration of 3'-azide'-deoxythymidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191005